LYV vs XERS · P/E 49, rev $11.46B vs rev $175.2M
Live Nation Entertainment Inc (LYV) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
Live Nation Entertainment Inc (LYV) is a entertainment company listed on US.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported LYV revenue for 2026-06-30 was $11.46B. Net income was -$94.7M. LYV currently screens at market cap $33.36B and trailing P/E 48.8.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
LYV currently screens at market cap $33.36B and trailing P/E 48.8. XERS currently screens at market cap $760.7M.
Not investment advice. Open the LYV and XERS stock pages for the full models.
Not investment advice.